- Home
- WKEY vs COCP Comparison
WKEY vs COCP Comparison
Compare WKEY & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- COCP
- Stock Information
- Founded
- WKEY 1999
- COCP 2006
- Country
- WKEY Switzerland
- COCP United States
- Employees
- WKEY N/A
- COCP N/A
- Industry
- WKEY EDP Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- COCP Health Care
- Exchange
- WKEY Nasdaq
- COCP Nasdaq
- Market Cap
- WKEY 86.9M
- COCP 15.7M
- IPO Year
- WKEY N/A
- COCP N/A
- Fundamental
- Price
- WKEY $6.56
- COCP $1.49
- Analyst Decision
- WKEY Strong Buy
- COCP Strong Buy
- Analyst Count
- WKEY 1
- COCP 1
- Target Price
- WKEY $4.00
- COCP $6.00
- AVG Volume (30 Days)
- WKEY 254.4K
- COCP 25.2K
- Earning Date
- WKEY 07-07-2025
- COCP 08-13-2025
- Dividend Yield
- WKEY N/A
- COCP N/A
- EPS Growth
- WKEY N/A
- COCP N/A
- EPS
- WKEY N/A
- COCP N/A
- Revenue
- WKEY $11,875,000.00
- COCP N/A
- Revenue This Year
- WKEY $18.18
- COCP N/A
- Revenue Next Year
- WKEY $112.51
- COCP N/A
- P/E Ratio
- WKEY N/A
- COCP N/A
- Revenue Growth
- WKEY N/A
- COCP N/A
- 52 Week Low
- WKEY $1.61
- COCP $1.12
- 52 Week High
- WKEY $14.00
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- WKEY 52.67
- COCP 45.79
- Support Level
- WKEY $5.14
- COCP $1.48
- Resistance Level
- WKEY $7.12
- COCP $1.58
- Average True Range (ATR)
- WKEY 0.60
- COCP 0.09
- MACD
- WKEY -0.06
- COCP -0.01
- Stochastic Oscillator
- WKEY 58.76
- COCP 15.38
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).